4-tert-butyl-2-[3-(3-methylimidazol-3-ium-1-yl)phenoxy]-6-(9-phenylfluoren-9-yl)pyridine
C38H34N3O+ — CID 155614496
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-tert-butyl-2-[3-(3-methylimidazol-3-ium-1-yl)phenoxy]-6-(9-phenylfluoren-9-yl)pyridine
4-tert-butyl-2-[3-(3-methylimidazol-3-ium-1-yl)phenoxy]-6-(9-phenylfluoren-9-yl)pyridine (PubChem CID 155614496) has the molecular formula C38H34N3O+ and a molecular weight of 548.71 g/mol. Its IUPAC name is 4-tert-butyl-2-[3-(3-methylimidazol-3-ium-1-yl)phenoxy]-6-(9-phenylfluoren-9-yl)pyridine.
Molecular Properties
| Compound Name | 4-tert-butyl-2-[3-(3-methylimidazol-3-ium-1-yl)phenoxy]-6-(9-phenylfluoren-9-yl)pyridine |
|---|---|
| PubChem CID | 155614496 |
| Molecular Formula | C38H34N3O+ |
| Molecular Weight | 548.71 g/mol |
| Exact Mass | 548.27 |
| IUPAC Name | 4-tert-butyl-2-[3-(3-methylimidazol-3-ium-1-yl)phenoxy]-6-(9-phenylfluoren-9-yl)pyridine |
| SMILES | C[n+]1ccn(-c2cccc(Oc3cc(C(C)(C)C)cc(C4(c5ccccc5)c5ccccc5-c5ccccc54)n3)c2)c1 |
| InChI | InChI=1S/C38H34N3O/c1-37(2,3)28-23-35(39-36(24-28)42-30-16-12-15-29(25-30)41-22-21-40(4)26-41)38(27-13-6-5-7-14-27)33-19-10-8-17-31(33)32-18-9-11-20-34(32)38/h5-26H,1-4H3/q+1 |
| InChIKey | WZUGXBNFOUJFBG-UHFFFAOYSA-N |
| XLogP | 8.15 |
| TPSA | 30.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 548.71 |
| LogP ≤ 5 | 8.15 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155614496 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.